+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Chorionic Gonadotropin (hCG). Edition No. 2

  • ID: 3049092
  • Book
  • October 2018
  • Region: Global
  • 446 Pages
  • Elsevier Science and Technology
1 of 3

Human chorionic gonadotropin (hCG) is produced during pregnancy by the embryo. It promotes progesterone production by corpus luteal cells. It also functions in pregnancy to promote angiogenesis in uterine vasculature, it immuno-blands the invading placental tissue so it is not rejected by the maternal uterine tissues, promotes the growth of the uterus in line with the growth of the fetus, promotes the differentiation of growing cytotrophoblast cells, promotes the quiescence of contractions in the uterine myometrium during the course of pregnancy, and also has function in growth and development of fetal organs.

The first edition described the detailed biology, clinical chemistry, and clinical perspectives of hCG and associated molecules, and examines hCG, hyperglycosylated hCG and hCG free ß-subunit, 3 separate and independent molecules with totally sovereign physiological functions.

The second edition will include coverage of the many new discoveries that have been made in the last five years: hCG analogues may be the actual driving signal of all human cancers. The editor estimates that 40% of the out of date material will be excluded and replaced with 40% of the exciting new findings. The book will also have a much clearer pregnancy and cancer focus.

  • It provides comprehensive information on hCG from basic science to clinical medicine
  • The second edition will include coverage of the many new discoveries that have been made in the last five years
  • Updated material with new findings in the field
Note: Product cover images may vary from those shown
2 of 3

Part A. Introduction

Part B. Synthesis, Structure and Action Site

Part C. Continuous Dissociation and Degradation

Part D. Biological Function: Pregnancy

Part E. Biological Function: Normal Pituitary

Part F. Biological Function: Evolution

Part G. Biological Function: Gestational Trophoblastic Disease

Part H. Biological Function: Cancer

Part I. Clinical Applications

Part J. Assays and Antibodies

Part K. Test Applications and Standards

Part L. Methods

Part M. Ethics, Comments and the Future

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Cole, Laurence A.
Dr. Cole has served on the journal editorial board from 1994-2001 as the Editor of "Trophoblast Disease Update". He has written more than 100 articles on hCG structure, physiology and immunoassay and on clinical applications of hCG or hCG-related molecules. He has a 1.17 FWCI in the Medicine category of SciVal where he has published throughout the various disciplines and maintains an average of 12.6 citations per article from 2009-2014. He has experience with international, single, and institutional collaboration. Awards and recognition for Dr. Cole include the Institute for Anticancer Research, Biannual Prize for best research; American Association for Clinical Chemistry, Most Outstanding Research Contributor to Clinical Chemistry Prize; Gynecology Oncology, Outstanding Speaker Award; and International Society for Study of Trophoblastic Disease, Gold Medal for most outstanding research.
Note: Product cover images may vary from those shown
Adroll
adroll